Viewing data from:

PERPHENAZINE

ANDA

PERPHENAZINE | A205056 | RISING PHARMA HOLDINGS INC

4 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$0.4748

per ea

Lowest NADAC/Unit

$0.1413

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
64980029301PERPHENAZINE 16 MG TABLET	$0.4748	EA	Generic	—	2026-06-17
64980029001PERPHENAZINE 2 MG TABLET	$0.1947	EA	Generic	—	2026-06-17
64980029201PERPHENAZINE 8 MG TABLET	$0.1867	EA	Generic	—	2026-06-17
64980029101PERPHENAZINE 4 MG TABLET	$0.1413	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain5 active DMFs3 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

TRIFARMA SPAPERPHENAZINE USP

DMF 41301981

APICORE PHARMACEUTICALS PRIVATE LTDPERPHENAZINE USP

DMF 246462012

EMCURE PHARMACEUTICALS LTDPERPHENAZINE USP

DMF 272242013

MACLEODS PHARMACEUTICALS LTDPERPHENAZINE

DMF 307562016

JUBILANT BIOSYS LTDPERPHENAZINE USP

DMF 313792017

ORION CORP LTDInactivePERPHENAZINE

DMF 32731978

ORCHIMIE SA (PRODUITS CHIMIQUES ET BIOCHIMIQUES)InactivePERPHENAZINE

DMF 66451986

FINE CHEMICALS CORPInactivePERPHENAZINE

DMF 85561990

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (4)

Sort:

#001 — 2MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Mar 1, 2019

No patent or exclusivity listings for this strength.

#002 — 4MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Mar 1, 2019

#003 — 8MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Mar 1, 2019

#004 — 16MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Mar 1, 2019